Results 21 to 30 of about 29,894 (207)

Type 1 Autoimmune Pancreatitis in a Teenager With Ulcerative Colitis: A Case Report [PDF]

Gastro Hep Advances
Type 2 autoimmune pancreatitis (AIP) is a recognized complication of ulcerative colitis (UC), whereas type 1 AIP—an immunoglobulin G4-related sclerosing pancreatitis—is uncommon in this patient population and typically presents in older males. We present
Jerry H. Rose, Michael J. Sikorski, Patrick W. Ruane, Dania Hudhud, Abdulhameed M. Al-Sabban   +4 more
doaj   +2 more sources

Autoimmune pancreatitis

Zdravniški Vestnik, 2007
Background: Autoimmune pancreatitis is a recently described type of pancreatitis of presumed autoimmune etiology. Autoimmune pancreatitis is often misdiagnosed as pancreatic cancer difficult, since their clinical presentations are often similar.
Davorin Dajčman
doaj   +2 more sources

Autoimmune pancreatitis type 1 and type 2: what we know so far

Quality in Sport
Autoimmune pancreatitis (AIP) is a unique form of chronic pancreatitis characterized by lymphoplasmacytic infiltration, pancreatic fibrosis, and responsiveness to steroid therapy.
Marta Piotrowska, Julita Gmitrzuk, Zuzanna Malinka, Katarzyna Wiśniewska, Anna Jachymek, Martyna Opatowska, Joanna Jakubiec, Tomasz Kucharski   +7 more
doaj   +2 more sources

EXTRA-PANCREATIC MANIFESTATION IN AUTOIMMUNE PANCREATITIS VERSUS CONVENTIONAL PANCREATITIS: AN EGYPTIAN COHORT [PDF]

Arquivos de Gastroenterologia
Background: Autoimmune pancreatitis (AIP) is a specific form of pancreatitis that is characterized by obstructive jaundice and sometimes associated with pancreatic masses, lymphoplasmacytic infiltrate and fibrosis, with a marked response to steroids ...
Rania A M ABOUYOUSSEF, Mohamed Saied ABDELGAWAD, Mahmoud AGHA, Marwa IBRAHIM   +3 more
doaj   +2 more sources

Autoimmune pancreatitis type 2 [PDF]

Current Opinion in Gastroenterology, 2020
Purpose of review Type 2 autoimmune pancreatitis (AIP) is a rare inflammatory disease of the pancreas. Very few data have been published on this particular subtype, which differs from the ‘classical’ IgG4-related type 1 AIP in terms of pathological features, epidemiology and risk of relapse.
de Pretis, Nicolò, Frulloni, Luca
openaire   +4 more sources

Autoimmune pancreatitis: What we know so far

JGH Open, 2022
Autoimmune pancreatitis (AIP) is a rare, often‐missed disease that involves inflammation of the pancreas and strictures of the pancreatic duct. Its prevalence and incidence in the United States remain scarce.
Muaaz Masood
doaj   +1 more source

Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double‐blind, placebo‐controlled clinical trial

Hepatology, EarlyView., 2022
NRPT 1X reduces ALT and ceramide 14:0 in 65% of subjects as compared to only 28% in the placebo group. Abstract Background and Aims The prevalence of NAFLD is increasing globally and on a path to becoming the most frequent cause of chronic liver disease. Strategies for the prevention and treatment of NAFLD are urgently needed.
Ryan W. Dellinger, Holly E. Holmes, Tina Hu‐Seliger, Rodney W. Butt, Stephen A. Harrison, Dariush Mozaffarian, Oliver Chen, Leonard Guarente   +7 more
wiley   +1 more source

Adolescent Type 2 Autoimmune Pancreatitis

The Korean Journal of Medicine, 2020
There are two forms of autoimmune pancreatitis (AIP). Type 1 is associated with immunoglobulin G4 (IgG4)-related systemic fibro- inflammatory disease, whereas type 2 AIP is localized to the pancreas and not associated with IgG4. The number of children presenting with type 2 AIP has recently increased.
So Hyun Kim, Seung-Ho Baek, Hye Yeong Kim, Su Jin Choi, Ji Hoon Kim, Se Hee Lee, Myung-Hwan Kim   +6 more
openaire   +1 more source

What's in a Name? Classification of Diabetes Mellitus in Veterinary Medicine and Why It Matters [PDF]

, 2016
Diabetes Mellitus (DM) is a syndrome caused by various etiologies. The clinical manifestations of DM are not indicative of the cause of the disease, but might be indicative of the stage and severity of the disease process.
Abdul-Rasoul, Agarwal, Ahlgren, Alejandro, American Diabetes Association, Anderson, Appleton, Atkins, Atkins, Batchelor, Belle, Bostrom, Brackeva, Brenner, Butler, Catchpole, Catchpole, Chiang, Concannon, Coppieters, Cui, Das, Davison, Davison, Davison, De Cock, Eigenmann, Fajans, Fall, Forcada, Forcada, Forsberg, Furrer, Gepts, Gilor, Gilor, Gilor, Girman, Goossens, Gostelow, Gottlieb, Guptill, Haines, Hall, Herold, Hess, Hewson-Hughes, Hoenig, Hoenig, Hoffmann, Holst, Hume, Imamura, Jensen, Kappe, Kennedy, Kenny, Kilpatrick, Kim, Kitamura, Klupa, Kramer, Kramer, Lem, Ling, Link, Lutz, Mattin, McDonald, Miceli, Michels, Neiger, Nelson, Nelson, Niessen, Niessen, Nishii, Orban, Panciera, Papa, Pietropaolo, Porte, Porte, Prahl, Prasad, Rand, Ranta, Reaven, Russell-Jones, Safra, Scudder, Shields, Slingerland, Solanki, Strage, Sun, Temple, Thomas, Vegiopoulos, Verkest, Watson, Watson, Williams, Xenoulis, Yang, Zini, Zini, Zini, Zini, Zini, Zini   +110 more
core   +3 more sources

Blockade but not overexpression of the junctional adhesion molecule C influences virus-induced type 1 diabetes in mice [PDF]

, 2013
Type 1 diabetes (T1D) results from the autoimmune destruction of insulin-producing beta-cells in the pancreas. Recruitment of inflammatory cells is prerequisite to beta-cell-injury.
Aurrand-Lions, Michel, Bayer, Monika, Christen, Selina, Christen, Urs, Coppieters, Ken, Herrath, Matthias G. von, Hintermann, Edith, Holdener, Martin, Imhof, Beat A., Pfeilschifter, Josef Martin (Prof. Dr.), Rose, Kerstin   +10 more
core   +3 more sources